相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Identification of the In Vivo Pharmacokinetics and Pharmacodynamic Driver of Iclaprim
Jee Hyun Park et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Surveillance of iclaprim activity: In vitro susceptibility of gram-positive pathogens collected from 2012 to 2014 from the United States, Asia Pacific, Latin American and Europe
David B. Huang et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Pooled analysis of the phase 3 REVIVE trials: randomised, double-blind studies to evaluate the safety and efficacy of iclaprim versus vancomycin for treatment of acute bacterial skin and skin-structure infections
David B. Huang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)
An Updated Review of Iclaprim: A Potent and Rapidly Bactericidal Antibiotic for the Treatment of Skin and Skin Structure Infections and Nosocomial Pneumonia Caused by Gram-Positive Including Multidrug-Resistant Bacteria
David B. Huang et al.
OPEN FORUM INFECTIOUS DISEASES (2018)
A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of Intravenous Iclaprim Vs Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections Suspected or Confirmed to be Due to Gram-Positive Pathogens: REVIVE-1
David B. Huang et al.
CLINICAL INFECTIOUS DISEASES (2018)
Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure
Abraham Pulido-Cejudo et al.
THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2017)
In Vitro Activity of Iclaprim against Methicillin-Resistant Staphylococcus aureus Nonsusceptible to Daptomycin, Linezolid, or Vancomycin: A Pilot Study
David B. Huang et al.
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY (2017)
Executive Summary: Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
Dennis L. Stevens et al.
CLINICAL INFECTIOUS DISEASES (2014)
Staphylococcal superantigens interact with multiple host receptors to cause serious diseases
Christopher S. Stach et al.
IMMUNOLOGIC RESEARCH (2014)
Bacteriophage therapy: a potential solution for the antibiotic resistance crisis
Zhabiz Golkar et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2014)
The antimicrobial resistance crisis: causes, consequences, and management
Carolyn Anne Michael et al.
FRONTIERS IN PUBLIC HEALTH (2014)
Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess
Jenana Halilovic et al.
JOURNAL OF INFECTION (2012)
Considerations when prescribing trimethoprim-sulfamethoxazole
Joanne M. -W. Ho et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Multicenter, Randomized Study of the Efficacy and Safety of Intravenous Iclaprim in Complicated Skin and Skin Structure Infections
D. Krievins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections
Andrew Morgan et al.
FUTURE MICROBIOLOGY (2009)
Increased hydrophobic interactions of iclaprim with Staphylococcus aureus dihydrofolate reductase are responsible for the increase in affinity and antibacterial activity
Christian Oefner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
分享论文
